{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:42:49Z","timestamp":1764175369678},"reference-count":28,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej22-0509","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T22:16:37Z","timestamp":1675203397000},"page":"501-509","source":"Crossref","is-referenced-by-count":3,"title":["Very young children with Prader-Willi syndrome are refractory to growth hormone-associated decreases in free thyroxine levels"],"prefix":"10.1507","volume":"70","author":[{"given":"Ayako","family":"Konishi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women\u2019s and Children\u2019s Hospital, Izumi 594-1101, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women\u2019s and Children\u2019s Hospital, Izumi 594-1101, Japan"},{"name":"Department of Pediatrics, Yodogawa Christian Hospital, Osaka 533-0024, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Etani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women\u2019s and Children\u2019s Hospital, Izumi 594-1101, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Ida","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Osaka Women\u2019s and Children\u2019s Hospital, Izumi 591-1101, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women\u2019s and Children\u2019s Hospital, Izumi 594-1101, Japan"},{"name":"Department of Bone and Mineral Research, Research Institute, Osaka Women\u2019s and Children\u2019s Hospital, Izumi 594-1101, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14: 10\u201326.","DOI":"10.1038\/gim.0b013e31822bead0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Angulo MA, Butler MG, Cataletto ME (2015) Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 38: 1249\u20131263.","DOI":"10.1007\/s40618-015-0312-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Tauber M, Hoybye C (2021) Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. Lancet Diabetes Endocrinol 9: 235\u2013246.","DOI":"10.1016\/S2213-8587(21)00002-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Nagai T, Obata K, Tonoki H, Temma S, Murakami N, et al. (2005) Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 136: 45\u201348.","DOI":"10.1002\/ajmg.a.30777"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, et al. (2001) Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 38: 792\u2013798.","DOI":"10.1136\/jmg.38.11.792"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Schmidt H, Schwarz HP, Enders A (2001) Dietary intervention in the first four years prevents abnormal weight gain but negatively affects height development in Prader-Willi syndrome. Acta Paediatr 90: 468\u2013469.","DOI":"10.1111\/j.1651-2227.2001.tb00456.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Schmidt H, Pozza SB, Bonfig W, Schwarz HP, Dokoupil K (2008) Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up. J Pediatr Endocrinol Metab 21: 651\u2013655.","DOI":"10.1515\/JPEM.2008.21.7.651"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Deal CL, Tony M, Hoybye C, Allen DB, Tauber M, et al. (2013) GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 98: E1072\u2013E1087.","DOI":"10.1210\/jc.2012-3888"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Passone CGB, Franco RR, Ito SS, Trindade E, Polak M, et al. (2020) Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis. BMJ Paediatr Open 4: e000630.","DOI":"10.1136\/bmjpo-2019-000630"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Luo Y, Zheng Z, Yang Y, Bai X, Yang H, et al. (2021) Effects of growth hormone on cognitive, motor, and behavioral development in Prader-Willi syndrome children: a meta-analysis of randomized controlled trials. Endocrine 71: 321\u2013330.","DOI":"10.1007\/s12020-020-02547-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Donze SH, Damen L, Mahabier EF, Hokken-Koelega ACS (2020) Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment. Eur J Endocrinol 182: 405\u2013411.","DOI":"10.1530\/EJE-19-0479"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Festen DA, Visser TJ, Otten BJ, Wit JM, Duivenvoorden HJ, et al. (2007) Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Clin Endocrinol (Oxf) 67: 449\u2013456.","DOI":"10.1111\/j.1365-2265.2007.02910.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Vaiani E, Herzovich V, Chaler E, Chertkoff L, Rivarola MA, et al. (2010) Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life. Clin Endocrinol (Oxf) 73: 546\u2013550.","DOI":"10.1111\/j.1365-2265.2010.03840.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Konishi A, Ida S, Shoji Y, Etani Y, Kawai M (2021) Central hypothyroidism improves with age in very young children with Prader-Willi syndrome. Clin Endocrinol (Oxf) 94: 384\u2013391.","DOI":"10.1111\/cen.14323"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Iughetti L, Vivi G, Balsamo A, Corrias A, Crino A, et al. (2019) Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients. J Pediatr Endocrinol Metab 32: 159\u2013165.","DOI":"10.1515\/jpem-2018-0388"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Wyatt DT, Gesundheit N, Sherman B (1998) Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: lack of need for thyroxine supplementation. J Clin Endocrinol Metab 83: 3493\u20133497.","DOI":"10.1210\/jc.83.10.3493"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Portes ES, Oliveira JH, MacCagnan P, Abucham J (2000) Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children. Clin Endocrinol (Oxf) 53: 183\u2013189.","DOI":"10.1046\/j.1365-2265.2000.01071.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, et al. (2002) Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? J Clin Endocrinol Metab 87: 2042\u20132045.","DOI":"10.1210\/jcem.87.5.8479"},{"key":"#cr-split#-19.1","unstructured":"19 Isojima T, Kato N, Ito Y, Kanzaki S, Murata M (2016) Growth standard charts for Japanese children with mean and standard deviation"},{"key":"#cr-split#-19.2","unstructured":"(SD) values based on the year 2000 national survey. Clin Pediatr Endocrinol 25: 71-76."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, et al. (2011) Nutritional phases in Prader-Willi syndrome. Am J Med Genet A 155A: 1040\u20131049.","DOI":"10.1002\/ajmg.a.33951"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Koizumi M, Konishi A, Etani Y, Ida S, Kawai M (2022) Circulating insulin-like growth factor 1 levels are reduced in very young children with Prader-Willi syndrome independent of anthropometric parameters and nutritional status. Clin Endocrinol (Oxf) 96: 346\u2013352.","DOI":"10.1111\/cen.14635"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kato N, Takimoto H, Sudo N (2011) The cubic functions for spline smoothed L, S and M values for BMI reference data of Japanese children. Clin Pediatr Endocrinol 20: 47\u201349.","DOI":"10.1297\/cpe.20.47"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, et al. (2012) Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J 59: 771\u2013780.","DOI":"10.1507\/endocrj.EJ12-0110"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Rose SR, Leong GM, Yanovski JA, Blum D, Heavner G, et al. (1995) Thyroid function in non-growth hormone-deficient short children during a placebo-controlled double blind trial of recombinant growth hormone therapy. J Clin Endocrinol Metab 80: 320\u2013324.","DOI":"10.1210\/jc.80.1.320"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Oto Y, Murakami N, Matsubara K, Saima S, Ogata H, et al. (2020) Effects of growth hormone treatment on thyroid function in pediatric patients with Prader-Willi syndrome. Am J Med Genet A 182: 659\u2013663.","DOI":"10.1002\/ajmg.a.61499"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR (2005) Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115: 2524\u20132533.","DOI":"10.1172\/JCI25083"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Morreale de Escobar G, Obregon MJ, Escobar del Rey F (2004) Role of thyroid hormone during early brain development. Eur J Endocrinol 151 Suppl 3: U25\u2013U37.","DOI":"10.1530\/eje.0.151u025"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/5\/70_EJ22-0509\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:45:22Z","timestamp":1715316322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/5\/70_EJ22-0509\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej22-0509","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ22-0509"}}